Bridgeway Capital Management, LLC Biogen Inc. Transaction History

Bridgeway Capital Management, LLC

$4.14 Billion
Q2 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 2,000 shares of BIIB stock, worth $347,580. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,000

Previous 7,800 74.36%

Holding current value

$347,580

Previous $1.68 Million 72.46%

% of portfolio

0.01%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $1.11 Million - $1.37 Million	-5,800 Reduced 74.36%	2,000 $463,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $923,748 - $1.11 Million	-4,150 Reduced 34.73%	7,800 $2.02 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $4.56 Million - $5.15 Million	-18,000 Reduced 60.1%	11,950 $3.07 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $1.38 Million - $1.59 Million	-5,000 Reduced 14.31%	29,950 $8.53 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1.41 Million - $1.61 Million	5,500 Added 18.68%	34,950 $9.72 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $5.73 Million - $7.91 Million	29,450 New	29,450 $7.86 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $9.21 Million - $11 Million	-49,105 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $5.16 Million - $6.5 Million	-26,640 Reduced 35.17%	49,105 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $253,029 - $325,180	-1,130 Reduced 1.47%	75,745 $18.2 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.46 Million - $3.21 Million	-8,700 Reduced 10.17%	76,875 $21.8 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $2.68 Million - $4.3 Million	-10,365 Reduced 10.8%	85,575 $29.6 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $66,811 - $78,273	275 Added 0.29%	95,940 $26.8 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.98 Million - $2.99 Million	-8,400 Reduced 8.07%	95,665 $23.4 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $13.9 Million - $16 Million	-52,400 Reduced 33.49%	104,065 $29.5 Million
Q2 2020 Aug 31, 2020	BUY	$258.66 - $342.55 $775,980 - $1.03 Million	3,000 Added 1.95%	156,465 $41.9 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $5.13 Million - $6.8 Million	-19,840 Reduced 11.45%	153,465 $41.1 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $12.8 Million - $16.2 Million	-47,570 Reduced 21.54%	173,305 $54.8 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $6.23 Million - $8.61 Million	-28,300 Reduced 11.36%	220,875 $65.5 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $7.87 Million - $8.82 Million	36,175 Added 16.98%	249,175 $58 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $46.7 Million - $51.5 Million	213,000 New	213,000 $49.8 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Biogen Inc. Transaction History